Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma

• Bert H. O’Neil ,

  Roles Data curation, Formal analysis, Writing – original draft, Writing – review & editing

  * E-mail: bhoneil@iu.edu

  Affiliation Department of Hematology/Oncology, Indiana University Simon Cancer Center, Indianapolis, Indiana, United States of America

  http://orcid.org/0000-0001-7032-7453

  ⨯
• John M. Wallmark,

  Roles Data curation, Writing – review & editing

  Affiliation Department of Hematology/Oncology, Maryland Hematology Oncology, Rockville, Maryland, United States of America

  ⨯
• David Lorente,

  Roles Data curation, Formal analysis, Writing – review & editing

  Affiliation Prostate Cancer Targeted Therapy Group, The Royal Marsden, Sutton, United Kingdom

  ⨯
• Elena Elez,

  Roles Data curation, Formal analysis, Writing – review & editing

  Affiliation Vall d’Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain

  ⨯
• Judith Raimbourg,

  Roles Data curation, Writing – review & editing

  Affiliation Department of Oncology Medical, Institut de Cancérologie de l’Ouest, Nantes, France

  ⨯
• Carlos Gomez-Roca,

  Roles Data curation, Formal analysis, Writing – review & editing

  Affiliation Department of Oncology Medical, Institut Claudius Regaud and IUCT-Oncopole, Toulouse, France

  ⨯
• Samuel Ejadi,

  Roles Formal analysis, Writing – review & editing

  Affiliation Department of Oncology, Scottsdale Healthcare, Virginia G. Piper Cancer Center, Scottsdale, Arizona, United States of America

  ⨯
• Sarina A. Piha-Paul,

  Roles Data curation, Writing – original draft, Writing – review & editing

  Affiliation Department of Investigational Clinical Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Mark N. Stein,

  Roles Data curation, Formal analysis, Writing – review & editing

  Affiliation Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America

  ⨯
• Albiruni R. Abdul Razak,

  Roles Data curation, Formal analysis, Writing – review & editing

  Affiliation Clinical Cancer Research Unit, Princess Margaret Cancer Centre, Toronto, Canada

  ⨯
• Katia Dotti,

  Roles Data curation, Writing – review & editing

  Affiliation Department of Medical Oncology, Fondazione I.R.C.C.S. Istituto Nazionale dei Tumori, Milan, Italy

  ⨯
• Armando Santoro,

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  Affiliation Humanitas Cancer Center, Humanitas Research Hospital, Rozzano, Italy

  ⨯
• Roger B. Cohen,

  Roles Formal analysis, Writing – review & editing

  Affiliation Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Marlena Gould,

  Roles Formal analysis, Writing – review & editing

  Affiliation Department of Clinical Research, Merck & Co., Inc., Kenilworth, New Jersey, United States of America

  ⨯
• Sanatan Saraf,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Department of Clinical Research, Merck & Co., Inc., Kenilworth, New Jersey, United States of America

  ⨯
• Karen Stein,

  Roles Data curation, Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Department of Clinical Research, Merck & Co., Inc., Kenilworth, New Jersey, United States of America

  ⨯
•  [ ... ],
• Sae-Won Han

  Roles Data curation, Writing – review & editing

  Affiliation Division of Hematology and Medical Oncology, Seoul National University Hospital, Seoul, Republic of Korea

  ⨯
• [ view all ]
• [ view less ]